Search clinical trials

Results for SEARCH ALL

Total 285016 results
Search term:


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 5414 5415 5416 5417 5418 5419 5420 5421 5422 5423 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 Last


#
NCTID/Status
Study
Last Changed

271651
NCT00118638
Completed
April 25, 2013

271652
NCT00118625
Completed
June 16, 2010


271654
NCT00118586
Active, not recruiting
Neuropathology of Spasmodic Dysphonia

Conditions: Voice Disorders
August 8, 2018

271655
NCT00118573
Terminated
Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

Conditions: Aortic Aneurysm, Abdominal; Endovascular
December 9, 2015

271656
NCT00118560
Completed
Exercise Training for Patients With Poor Leg Circulation

Conditions: Diabetes Mellitus, Type 2; Intermittent Claudication
March 16, 2011

271657
NCT00118547
Completed
August 11, 2011

271658
NCT00118534
Completed
Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder

Conditions: Mental Health; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Tobacco Use Disorder
April 18, 2014

271659
NCT00118521
Completed
December 18, 2013


271661
NCT00118495
Completed
Zestra in Women With Mixed Sexual Dysfunction

Conditions: Sexual Dysfunction, Psychological
July 4, 2007

271662
NCT00118482
Completed
Clinical Trial for the Prevention of Vasovagal Syncope

Conditions: Syncope, Vasovagal, Neurally-Mediated
May 25, 2017

271663
NCT00118469
Unknown status
April 1, 2008

271664
NCT00118456
Completed
January 5, 2012

271665
NCT00118443
Completed
June 27, 2013

271666
NCT00118430
Completed
March 28, 2017

271667
NCT00118417
Completed
June 5, 2014

271668
NCT00118404
Completed
May 13, 2014

271669
NCT00118391
Completed
Cognitive-Behavioral Treatment of Gambling

Conditions: Gambling; Mental Health
June 28, 2013

271670
NCT00118378
Completed
April 3, 2017

271671
NCT00118365
Completed
January 12, 2015

271672
NCT00118352
Completed
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Conditions: Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
April 25, 2017


271674
NCT00118326
Completed
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Conditions: Kidney Cancer; Leukemia; Lymphoma; Myelodysplastic Syndromes; Neuroblastoma; Sarcoma
May 12, 2010


271676
NCT00118300
Withdrawn
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Conditions: Cervical Cancer; Endometrial Cancer; Ovarian Cancer; Vaginal Cancer
July 7, 2011

271677
NCT00118287
Completed
Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes

Conditions: de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes
April 17, 2017


271679
NCT00118261
Completed
August 31, 2012

271680
NCT00118248
Completed
Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Conditions: Recurrent Thyroid Cancer; Stage IV Follicular Thyroid Cancer; Stage IV Papillary Thyroid Cancer; Thyroid Gland Medullary Carcinoma
December 28, 2016

271681
NCT00118235
Completed
June 16, 2014

271682
NCT00118222
Completed
High Light and Low Light Dose PDT in Glioma

Conditions: Brain and Central Nervous System Tumors
June 9, 2010

271683
NCT00118209
Active, not recruiting
July 9, 2018

271684
NCT00118196
Terminated
May 7, 2018

271685
NCT00118183
Completed
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Conditions: Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Large Cell Lung Cancer; Malignant Pleural Effusion; Recurrent Non-small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
June 3, 2013

271686
NCT00118170
Completed
Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Splenic Marginal Zone Lymphoma; Stage II Multiple Myeloma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia
January 4, 2013

271687
NCT00118157
Completed
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

Conditions: Estrogen Receptor Positive; Male Breast Carcinoma; Progesterone Receptor Positive; Recurrent Breast Carcinoma; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
October 27, 2017

271688
NCT00118144
Completed
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer

Conditions: Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; Non-small Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
August 4, 2014

271689
NCT00118131
Terminated
September 19, 2013

271690
NCT00118105
Withdrawn
January 2, 2013

271691
NCT00118092
Completed
17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Conditions: Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage IV Prostate Cancer
March 20, 2017

271692
NCT00118066
Terminated
Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Conditions: Precancerous/Nonmalignant Condition; Prostate Cancer
May 22, 2015

271693
NCT00118053
Terminated
September 17, 2013

271694
NCT00118040
Completed
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Conditions: Recurrent Bladder Cancer; Stage I Bladder Cancer; Stage II Bladder Cancer; Stage III Bladder Cancer
May 23, 2017

271695
NCT00118027
Completed
January 11, 2017

271696
NCT00118014
Completed
May 19, 2008

271697
NCT00118001
Completed
Psychotherapy of Generalized Anxiety Disorder

Conditions: Anxiety Disorders
March 31, 2015

271698
NCT00117988
Completed
17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Conditions: Anaplastic Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma
May 21, 2014




First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 5414 5415 5416 5417 5418 5419 5420 5421 5422 5423 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 Last




© 2018 ICH GCP